Novartis AG
As of Oct 26, 2026 close
- Market cap
- $294.39B
- P/E (TTM)
- 23.08
- Forward P/E
- 25.24
- Dividend yield
- 3.05%
- 52-week range
- $121.57$170.46
- Volume (live)
- -
- Avg. volume (3M)
- 1.92M
Novartis (NVS) Stock Price & Financial Analysis
Novartis Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $152.02 - $154.24 |
|---|---|
| 52-Week High | $170.46 |
| 52-Week Low | $121.57 |
| Open | $153.53 |
| Volume (last close) | 2.82M |
| Average Volume (3M) | 1.92M |
| Revenue (TTM) | 56.69B |
|---|---|
| Net Income (TTM) | 12.76B |
| Free Cash Flow (TTM) | 16.30B |
| EPS (TTM) | $6.63 |
| Profit Margin | 22.50% |
| Operating Margin | 30.17% |
| Return on Equity (ROE) | 30.41% |
| Debt to Equity | 1.12 |
| Annual Dividend | $3.08 |
|---|---|
| Dividend Yield | 3.05% |
| Payout Ratio | 72.01% |
| Last Dividend Ex-Date | Mar 11, 2026 |
| Market Cap | 294.39B |
|---|---|
| Shares Outstanding | 1.91B |
| P/E Ratio (TTM) | 23.08 |
| Forward P/E | 25.24 |
| Price to Sales (P/S) | 5.19 |
| Price to Book (P/B) | 7.02 |
| EV/EBITDA | 15.01 |
| 50-Day MA | $148.06 |
|---|---|
| 200-Day MA | $151.23 |
| 1-Year Change | +18.71% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Novartis at a Glance
As of the Oct 26, 2026 close, Novartis (NVS) has a market capitalization of $294.39B. The stock trades at 23.1× trailing earnings, 25.2× forward earnings and 5.2× sales. Over the trailing twelve months it earned $12.76B on revenue of $56.69B (a 22.5% profit margin) and generated $16.30B of free cash flow. Revenue grew 2.7% year over year.
As of its latest reported balance sheet, it holds $7.62B in cash and securities against $47.08B of debt, a net debt position of $39.46B.
Novartis pays a annual dividend totaling $3.08 per share a year, a 3.05% yield at the Oct 26, 2026 close, with a 72% payout ratio and 3 consecutive years of dividend increases.
The share price is up 18.7% over the past year. At $153.81 (the Oct 26, 2026 close) it sits within its 52-week range of $121.57 to $170.46, above its 200-day moving average of $151.23.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $163.20, 6.1% above the Oct 26, 2026 close.
Frequently Asked Questions About Novartis
What is the current stock price for NVS?
As of the Oct 26, 2026 close, NVS stock trades at $153.81. The 52-week range is $121.57–$170.46, with a day range of $152.02–$154.24.
What is the P/E ratio for NVS?
As of the Oct 26, 2026 close, Novartis's trailing twelve-month (TTM) P/E ratio is 23.1, meaning investors pay $23.1 for every $1 of annual earnings. The forward P/E is 25.2, reflecting analyst expectations for future earnings. Novartis operates in the Healthcare sector.
Does NVS pay dividends?
Yes, Novartis pays a 3.05% annual dividend yield as of the Oct 26, 2026 close ($3.08 per share a year). The trailing twelve-month payout ratio is 72.0%. The most recent ex-dividend date was March 11, 2026.
What do analysts recommend for NVS?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for NVS is Hold. The average 12-month price target is $163.20, a 6.1% upside from the Oct 26, 2026 close of $153.81.
What is the market cap of NVS?
As of the Oct 26, 2026 close, Novartis's market capitalization is $294.39B, classifying it as a mega-cap company. Novartis operates in the Healthcare sector within the Drug Manufacturers - General industry.